24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Beware of Hand Sanitizers Containing MethanolWhat Athletes Should Know About COVID-19, Heart Damage and Working OutCOVID-19 Causing More Stress in America Than Other Nations: SurveyWill Your Kid Play School Sports This Fall? Here's Some Guidance on Doing It SafelyScientists Call for Broader Use of Faster COVID TestsTwo Common Nutrients Might Keep Vertigo at BayPeople Are Dying, Going Blind After Drinking Hand Sanitizer, CDC WarnsMore Social Media Use, More Fake COVID NewsSkip the 'Maskne,' Not the MaskObesity Ups Odds for Severe COVID-19, But Age MattersSeven States Join Pact to Speed Coronavirus TestingStudy Casts Doubt on Value of Cholesterol DrugsCOVID-19 Fears Had Sick, Injured Americans Avoiding ERsCancer Diagnoses Plunge as Americans Avoid Screening During PandemicMysterious Paralyzing Illness in Kids Is Set to Return, CDC WarnsMany Older Americans Staying Strong in the PandemicCoronavirus Cases Now Climbing in the MidwestCould the First Drug That Slows Arthritis Be Here?Schools Can Reopen Safely If Precautions in Place, Australian Study ShowsFace Masks, Yes, But Don't Forget Hand-Washing TooEven With PPE, Risk of COVID-19 Still High for Frontline WorkersCoronavirus Pandemic Becoming Far More Widespread, Birx SaysGuard Against Lyme Disease This SummerKids 'Efficient' Transmitters as COVID-19 Raced Through a Georgia Summer CampCollege Students Will Need COVID Tests Every 2-3 Days for Campus Safety: StudyAHA News: Sustained High Blood Pressure May Damage Brain VesselsAnother Side Effect of COVID-19 -- Lasting Hearing Problems?Pandemic Could Complicate Hurricane SeasonStudy Reveals How Coronavirus Travels IndoorsNew Study Sheds Doubt on Notion Kids Aren't COVID-19 SpreadersAHA News: Are Virtual Doctor Visits Safe for Discharged Heart Failure Patients?Double Lung Transplants Save Lives of Sickest COVID PatientsGynecological Cancers Not a Risk for Severe COVID-19: Study11 States Could Face ICU Doc Shortages as Coronavirus Cases SurgeWildfire Pollution Puts Kidney Patients at RiskAmerica's Progress Against Early Cardiovascular Death Is SlowingAHA News: 5 Easy Ways to Keep Tabs on Heart HealthGene Study Shows How Coronavirus Swept Through the Diamond PrincessOne Disease Mosquitoes Don't Spread: CoronavirusU.S. Coronavirus Death Toll Surges Past 150,000Do Bedbugs Dirty the Air Inside Your Home?AHA News: New Test May Predict Who Develops Certain Type of Heart FailureLess Smoking, Drinking Means Fewer Hip Fractures for AmericansYet Another Study Finds Vaccines Are SafeCommon Diabetes Meds Linked to Higher Odds for a Serious ComplicationSurvivors' COVID Antibodies May Provide a Powerful GiftConcussion Ups Odds for Many Brain ConditionsFinal Coronavirus Vaccine Trials Get UnderwayAHA News: Flu Shot May Help Protect Vulnerable Hospital Patients From Heart Attack, Mini-StrokeCOVID-19 'Super Spreaders' Quickly Fill Room With Virus -- But Masks Help
Questions and AnswersLinks
Related Topics

Diabetes

Lab-Created Virus Can Help COVID-19 Research, Developers Say

HealthDay News
by -- Robert Preidt
Updated: Jul 27th 2020

new article illustration

MONDAY, July 27, 2020 (HealthDay News) -- A lab-created virus that's similar to but not as dangerous as the new coronavirus could aid efforts to create COVID-19 treatments and vaccines, according to scientists who created it.

Airborne and potentially deadly, the SARS-CoV-2 virus that causes COVID-19 must be studied under strict safety conditions. Precautions include full-body biohazard suits with pressurized respirators, and labs with multiple containment levels and specialized ventilation systems.

But many scientists lack access to such safety measures, slowing efforts to find drugs and vaccines. So a team of researchers at Washington University School of Medicine in St. Louis said they created a hybrid virus that doesn't require such extensive measures.

To create it, they replaced a gene in a mild virus with one from SARS-CoV-2. The hybrid virus infects cells and is recognized by antibodies just like SARS-CoV-2, but can be studied under ordinary laboratory safety protocols.

"I've never had this many requests for a scientific material in such a short period of time," said study co-author Sean Whelan, head of the university's Department of Molecular Microbiology.

"We've distributed the virus to researchers in Argentina, Brazil, Mexico, Canada and, of course, all over the U.S.," he said in a university news release. "We have requests pending from the U.K. and Germany. Even before we published, people heard that we were working on this and started requesting the material."

Researchers said the hybrid virus could help scientists evaluate a range of antibody-based preventives and treatments for COVID-19.

And since the hybrid virus looks like SARS-CoV-2 to the immune system, it's a potential vaccine candidate, researchers said. They're conducting animal studies to evaluate the possibility.

The study was recently published online in the journal Cell Host & Microbe.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.